publication venue for
- Should elective partial nephrectomy be performed for renal cell carcinoma >4 cm in size?. 5:482-3. 2008
- A case of port-site recurrence and locoregional metastasis after laparoscopic partial nephrectomy. 5:345-9. 2008
- Rational approach to the treatment of a patient with a small renal cortical tumor. 4:688-91. 2007
- Urolithiasis: The influence of stone size on management. 4:570-3. 2007
- Radical prostatectomy for clinical T3 disease: Expanding indications while optimizing cancer control and quality of life. 4:451-4. 2007
- A case of Castleman's disease that presented as a retroperitoneal mass. 4:285-8. 2007
- Mapping studies and modified templates in nonseminomatous germ cell tumors. 4:60-1. 2007
- A case of incidental adrenocortical oncocytoma. 3:618-21. 2006
- Adjuvant bicalutamide for early prostate cancer: An update: Commentary. 3:408-9. 2006
- Can preoperative behavioral training reduce postprostatectomy incontinence?: Commentary. 3:302-3. 2006
- Chylous ascites following retroperitoneal lymphadenectomy for testes cancer. 3:226-32; quiz 233. 2006
- Open partial nephrectomy: An essential contemporary operation. 3:2-3. 2006
- The importance of MRI evaluation in the preoperative work-up of prostate cancer. 2:565-71; quiz 572. 2005
- Interpreting data from randomized trials: The Scandinavian prostatectomy study illustrates two common errors. 2:404-5. 2005
- Imaging following cryoablation of a renal lesion. 2:52-7; quiz 58. 2005
- Thermal ablation: A potential solution for managing the small renal tumor. 2:2-3. 2005
- Does on-demand vardenafil improve erectile function recovery after radical prostatectomy?. 6:14-5. 2009
- High complication rates challenge the implementation of male circumcision for HIV prevention in Africa. 6:64-5. 2009
- Can imaging be used to assess treatment success after ablation of renal tumors?: Commnentary. 5:642-3. 2008
- Should vardenafil be used for the treatment of lower urinary tract symptoms associated with BPH?. 5:536-7. 2008
- Can excretory urography detect upper urinary tract tumors after radical cystectomy for urothelial cancer? Commentary. 5:302-3. 2008
- Is high-dose chemotherapy effective in patients with relapsed or refractory germ cell tumors? Commentary. 5:78-9. 2008
- Can indices determine the pathogenesis of age-related nocturia? Commentary. 5:16-7. 2008
- Is laparoscopic partial nephrectomy as effective as open partial nephrectomy in patients with renal cell carcinoma? Commentary. 5:12-3. 2008
- Is penile length after radical prostatectomy affected by nerve-sparing status and recovery of erectile function? Commentary. 5:20-1. 2008
- Is radical radiotherapy effective in patients with pT1G3 NXM0 bladder cancer? Commentary. 5:22-3. 2008
- Evidence for the usefulness of nomograms. 4:638-9. 2007
- How should we define patients who are at high risk of death from prostate cancer? Commentary. 4:646-7. 2007
- Is the number of lymph nodes removed during PLND related to the prevalence of lymph node invasion? Commentary. 4:528-9. 2007
- Is transurethral microwave thermotherapy comparable to transurethral resection for BPH? Commentary. 4:478-9. 2007
- How prevalent is neobladder emptying failure, and how can it be treated?: Commentary. 4:364-5. 2007
- Does difluoromethylornithine prevent recurrence in low-risk superficial bladder cancer?: Commentary. 4:240-1. 2007
- Is initial or delayed nephrectomy the optimal treatment for nonmetastatic Wilms' tumor?: Commentary. 4:244-5. 2007
- Organ-sparing techniques for penile cancer: Quo vadis?: Commentary. 4:182-3. 2007
- Does neurovascular bundle preservation at the time of radical prostatectomy improve urinary continence? Commentary. 4:138-9. 2007
- What is the prognostic significance of lymphovascular invasion in radical prostatectomy specimens? Commentary. 4:128-9. 2007
- Is lymphovascular invasion an important prognostic factor in patients with bladder cancer? Commentary. 3:188-189. 2006
- Does docetaxel plus prednisone prolong the survival of men with metastatic hormone-refractory prostate cancer?. 2:20-21. 2005
- Urologists and clinical trials. 5:229. 2008
- Urology: A long history of innovation. 5:59. 2008
- Localized prostate cancer is rarely a fatal disease. 5:1. 2008
- Surgeon's core values: Legitimizing the team concept in surgery. 4:635. 2007
- Are current staging systems for cancer serving us well?. 4:517. 2007
- Point of care testing: A welcome advance?. 4:401. 2007
- A hazard surgeons need to address. 4:347. 2007
- Intoxicated by technology: Are we keeping our eyes on the prize?. 4:231. 2007
- Prediction models in urology. 4:173. 2007
- Introduction: A multidisciplinary approach to genitourinary malignancy: Does this topic warrant further debate?. 4. 2007
- The responsible use of antibiotics for an elevated PSA level. 4:1. 2007
- Multimodal therapy for urologic cancers. 3:453. 2006
- Surgery in elderly cancer patients. 3:397. 2006
- Peer review: The importance of quality control. 3:345. 2006
- The role of outcomes research in improving patient care. 3:233. 2006
- The urologist and medical imaging. 3:175. 2006
- Supporting the support groups. 3:59. 2006
- Clinical research and the financial markets: Opportunities and risks. 2:573. 2005
- Nature Clinical Practice Urology: One year on. 2:517. 2005
- New technology and the changing world of cancer. 2:403. 2005
- How close are we to preventing prostate cancer?. 2:355. 2005
- The physician and conflict of interest. 2:113. 2005
- Information systems for urologists: The message from Mansoura, Egypt. 2:1. 2005
- Technique matters. 1:55. 2004
- Why a new journal?. 1:1. 2004
- Would gene therapy for the treatment of male infertility be safe? 2008
- What is the role of androgen deprivation therapy in the treatment of locally advanced prostate cancer? 2008
- Argument against frozen section analysis of distal ureters in transitional cell bladder cancer 2008
- Neoadjuvant chemotherapy for the treatment of muscle-invasive bladder cancer: Argument in favor 2008
- Surgery Insight: Optimizing open nerve-sparing radical prostatectomy techniques for improved outcomes 2007
- Advances in imaging for urologic procedures 2007
- Risk of transmission of genetic diseases by assisted reproduction 2007
- Management of patients with upper urinary tract transitional cell carcinoma 2007
- Surgery insight: Advances in techniques for open partial nephrectomy 2007
- The management of superficial bladder cancer 2007
- Multidisciplinary management of bone complications in prostate cancer and optimizing outcomes of bisphosphonate therapy 2007
- The medical management of Peyronie's disease 2007
- An argument to screen for distress in men diagnosed with early-stage prostate cancer: Commentary 2006
- PSA bounce versus biochemical failure following prostate brachytherapy: Commentary 2006
- Primer: Using decision analysis to improve clinical decision making in urology 2006
- Microsurgical management of male infertility 2006
- Technology Insight: Monoclonal antibody imaging of prostate cancer 2006
- Neuroendocrine differentiation in prostate cancer: A sheep in wolf's clothing? 2006
- Prostate-specific antigen doubling time as a prognostic marker in prostate cancer 2005
- Magnetic resonance imaging and magnetic resonance spectroscopic imaging of prostate cancer 2005
- The current status of laparoscopic retroperitoneal lymph node dissection for non-seminomatous germ-cell tumors 2005
- Botulinum toxin in urology: Evaluation using an evidence-based medicine approach 2004
- Surgical intervention in patients with metastatic renal cancer: Current status of metastasectomy and cytoreductive nephrectomy 2004
- Molecular pathways and the hope of targeting angiogenesis: Commentary 2007